ArticleFrontiers in microbiology2025
Construction of a predictive model for rebleeding risk in upper gastrointestinal bleeding patients based on clinical indicators such as
Article in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Development, validation, and web deployment of a rebleeding risk prediction model for acute non-variceal upper gastrointestinal bleeding in a Chinese population.Frontiers in medicine · 2025Article
- Analysis of factors associated with 1-year rebleeding in patients with acute upper gastrointestinal bleeding and a Glasgow- Blatchford Score ≥ 6 based on serological indicators.Frontiers in medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The annual incidence of upper gastrointestinal hemorrhage (UGIB) is about 60 cases/100,000 people, and about 40% of UGIB patients have hemorrhagic ulcers. Ulcer formation is often associated with Method: In this experiment, 254 patients with upper digestive tract hemorrhage from Shengjing Hospital affiliated to China Medical University were collected, and the clinical indicators and information of Results: In the correlation analysis between rebleeding and clinical data and related indicators, the risk of rebleeding in men (62.5%) was higher than that in women (43.47%), and the risk of rebleeding in patients with concurrent diseases (60.37%) was higher than that in patients without concurrent diseases. In the analysis of the correlation between the degree of infection and the laboratory test items, the hemoglobin level of patients will also change with the change of the degree of infection of patients ( Conclusion: Based on the degree of
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.